AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Precipio, Inc.

$26.73 +$2.91 (+12.24%)
NASDAQ · 14 Sep 2026 13:42 UTC
Previous Close
$27.32
Day Range
$26.73$27.3
Year Range
$16$33.63
Market Cap
47.69M
AVG Volume
89.9K
Trailing/Forward PE
-42.6/0.98
PEG ratio
-0.64
Dividend Yield
-
Next Earnings Date
2026-11-16
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PRPO Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q227.46M
26 Q126.09M
25 Q424.05M
25 Q321.52M
25 Q220.57M
25 Q119.36M
24 Q418.53M
24 Q317.41M
24 Q215.94M
24 Q115.03M
Net Income (USD) · TTM
-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PRPO Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2-1.22M
26 Q1-922K
25 Q4-363K
25 Q3-1.25M
25 Q2-1.8M
25 Q1-3.1M
24 Q4-4.29M
24 Q3-3M
24 Q2-3.83M
24 Q1-4.9M
Operating Income (USD) · TTM
-8M-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PRPO Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2-1.55M
26 Q1-1.77M
25 Q4-1.2M
25 Q3-2.08M
25 Q2-2.62M
25 Q1-3M
24 Q4-4.22M
24 Q3-4.73M
24 Q2-5.58M
24 Q1-6.67M
EBITDA (USD) · TTM
-4M-2M02M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PRPO EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2246K
26 Q1860K
25 Q41.39M
25 Q3363K
25 Q2-93K
25 Q1-1.47M
24 Q4-2.72M
24 Q3-1.52M
24 Q2-2.37M
24 Q1-3.43M
Cash Flows (USD) · TTM
-3M-2M-1M01M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PRPO Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2789K
26 Q1555K
25 Q4359K
25 Q3589K
25 Q2565K
25 Q1701K
24 Q4216K
24 Q3-240K
24 Q2-1.09M
24 Q1-2.75M
EPS (USD) · TTM
-4-3-2-1024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PRPO EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q2-0.65
26 Q1-0.48
25 Q4-0.26
25 Q3-0.84
25 Q2-1.21
25 Q1-2.09
24 Q4-2.96
24 Q3-2.06
24 Q2-2.68
24 Q1-3.73
Expenses (USD) · TTM
05M10M15M20MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PRPO Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q24.83M
26 Q1238K
25 Q4326K
25 Q34.79M
25 Q24.84M
25 Q18.27M
24 Q411.13M
24 Q311.42M
24 Q214.66M
24 Q115.66M
Shares Outstanding (USD) · TTM
-2M-1.5M-1M-500K0500KBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PRPO Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-1.3M
26 Q1-1.78M
25 Q4-1.21M
25 Q3-1.93M
25 Q2-1.84M
25 Q1-1.69M
24 Q4-1.63M
24 Q3-1.37M
24 Q2-1.59M
24 Q1-1.64M
Employee Count
0204060802013201720182019202020212022202320242025
PRPO Employee Count by quarter
PeriodEmployee Count
202561
202454
202351
202253
202155
202054
201950
201842
201731
20135
Free Cash Flow Yield
-15%-10%-5%0%5%10%med 1.46%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
PRPO Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 261.62%
Sep 261.61%
Aug 261.53%
Aug 261.45%
Aug 261.88%
Aug 261.3%
Jul 261.44%
Jul 261.31%
Jul 261.26%
Jul 261.31%
Jul 261.23%
Jun 261.34%
Jun 261.39%
Jun 261.41%
Jun 261.33%
May 261.37%
May 261.31%
May 261.2%
May 260.75%
May 260.72%
Apr 260.8%
Apr 260.79%
Apr 260.82%
Apr 260.88%
Mar 261.39%
Mar 261.29%
Mar 261.34%
Mar 261.36%
Feb 261.49%
Feb 261.42%
Feb 261.54%
Feb 261.79%
Jan 261.47%
Jan 261.47%
Jan 261.53%
Jan 261.45%
Jan 261.51%
Dec 251.51%
Dec 251.62%
Dec 251.44%
Dec 251.5%
Nov 251.48%
Nov 251.47%
Nov 251.86%
Nov 251.87%
Oct 251.82%
Oct 251.82%
Oct 252.16%
Oct 251.96%
Oct 251.8%
Sep 252.14%
Sep 252.24%
Sep 251.91%
Sep 252.1%
Aug 252.4%
Aug 252.62%
Aug 252.54%
Aug 253.36%
Aug 253.23%
Jul 253.17%
Jul 253.22%
Jul 252.99%
Jul 253.87%
Jun 254.29%
Jun 254.13%
Jun 254.3%
Jun 254.17%
May 254.94%
May 254.82%
May 255.92%
May 252.18%
May 251.98%
Apr 252.4%
Apr 252.46%
Apr 252.56%
Apr 252.74%
Mar 252.31%
Mar 25-2.39%
Mar 25-2.26%
Mar 25-2.34%
Feb 25-2.23%
Feb 25-1.6%
Feb 25-2.25%
Feb 25-2.44%
Jan 25-2.36%
Jan 25-2.48%
Jan 25-2.49%
Jan 25-2.64%
Jan 25-2.92%
Dec 24-2.94%
Dec 24-3.08%
Dec 24-2.79%
Dec 24-2.8%
Nov 24-2.73%
Nov 24-2.74%
Nov 24-2.62%
Nov 24-2.66%
Nov 24-11.83%
Oct 24-11.8%
Oct 24-11.56%
Price to Sales
00.511.522.5med 1.35Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
PRPO Price to Sales by quarter
PeriodPrice to Sales
Sep 261.78
Sep 261.78
Aug 261.88
Aug 261.98
Aug 261.53
Aug 261.64
Jul 261.48
Jul 261.62
Jul 261.68
Jul 261.63
Jul 261.73
Jun 261.59
Jun 261.53
Jun 261.51
Jun 261.61
May 261.56
May 261.63
May 261.78
May 261.99
May 262.06
Apr 261.87
Apr 261.89
Apr 261.82
Apr 261.7
Mar 261.98
Mar 262.12
Mar 262.04
Mar 262.02
Feb 261.83
Feb 261.93
Feb 261.78
Feb 261.53
Jan 261.87
Jan 261.87
Jan 261.79
Jan 261.88
Jan 261.81
Dec 251.81
Dec 251.69
Dec 251.9
Dec 251.83
Nov 251.85
Nov 251.86
Nov 251.47
Nov 251.47
Oct 251.51
Oct 251.51
Oct 251.27
Oct 251.4
Oct 251.53
Sep 251.28
Sep 251.23
Sep 251.44
Sep 251.31
Aug 251.14
Aug 251.05
Aug 251.08
Aug 251.08
Aug 251.12
Jul 251.14
Jul 251.13
Jul 251.21
Jul 250.94
Jun 250.84
Jun 250.88
Jun 250.84
Jun 250.87
May 250.73
May 250.75
May 250.61
May 250.53
May 250.59
Apr 250.49
Apr 250.47
Apr 250.46
Apr 250.42
Mar 250.51
Mar 250.58
Mar 250.61
Mar 250.59
Feb 250.62
Feb 250.86
Feb 250.61
Feb 250.57
Jan 250.58
Jan 250.56
Jan 250.55
Jan 250.52
Jan 250.47
Dec 240.47
Dec 240.45
Dec 240.49
Dec 240.49
Nov 240.5
Nov 240.5
Nov 240.53
Nov 240.52
Nov 240.58
Oct 240.58
Oct 240.59
EV/EBITDA
050100150200250med 106.27Nov 25Jan 26Feb 26Apr 26Jun 26Jul 26Sep 26
PRPO EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 26199.55
Sep 26200.13
Aug 26210.67
Aug 26222.29
Aug 26171.8
Aug 2650.73
Jul 2645.92
Jul 2650.13
Jul 2652.12
Jul 2650.38
Jul 2653.41
Jun 2649.36
Jun 2647.58
Jun 2646.85
Jun 2649.74
May 2648.3
May 2650.38
May 2655.02
May 2632.73
May 2634.04
Apr 2630.64
Apr 2630.98
Apr 2629.77
Apr 2627.63
Mar 26120.61
Mar 26129.23
Mar 26124.63
Mar 26123.14
Feb 26112.09
Feb 26117.86
Feb 26108.97
Feb 2693.95
Jan 26114.16
Jan 26114.21
Jan 26109.47
Jan 26115.2
Jan 26110.91
Dec 25110.64
Dec 25103.56
Dec 25116.1
Dec 25111.82
Nov 25113.21
Nov 25113.98
Nov 2590.66
Price/Operating Cashflow
020406080med 43.53Jun 25Aug 25Nov 25Jan 26Apr 26Jun 26Sep 26
PRPO Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2644.39
Sep 2644.52
Aug 2646.88
Aug 2649.48
Aug 2638.18
Aug 2653.9
Jul 2648.68
Jul 2653.25
Jul 2655.4
Jul 2653.51
Jul 2656.8
Jun 2652.41
Jun 2650.48
Jun 2649.69
Jun 2652.82
May 2651.27
May 2653.51
May 2658.55
May 2669.85
May 2672.5
Apr 2665.61
Apr 2666.31
Apr 2663.85
Apr 2659.52
Mar 2648.11
Mar 2651.64
Mar 2649.75
Mar 2649.14
Feb 2644.6
Feb 2646.98
Feb 2643.33
Feb 2637.16
Jan 2645.46
Jan 2645.48
Jan 2643.53
Jan 2645.88
Jan 2644.12
Dec 2544.01
Dec 2541.1
Dec 2546.25
Dec 2544.49
Nov 2545.07
Nov 2545.38
Nov 2535.81
Nov 2533.1
Oct 2533.93
Oct 2534.01
Oct 2528.55
Oct 2531.51
Oct 2534.39
Sep 2528.83
Sep 2527.62
Sep 2532.28
Sep 2529.36
Aug 2525.69
Aug 2523.6
Aug 2524.33
Aug 2519.67
Aug 2520.46
Jul 2520.8
Jul 2520.53
Jul 2522.04
Jul 2517.05
Jun 2515.38
Jun 2515.99
Jun 2515.35
Jun 2515.85
May 2513.36
May 2513.7
May 2511.15
May 2522.56
May 2524.91
Apr 2520.52
Apr 2520.01
Apr 2519.26
Apr 2517.93
Mar 2521.33
Price to Book
01234med 2.24Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
PRPO Price to Book by quarter
PeriodPrice to Book
Sep 263.31
Sep 263.32
Aug 263.49
Aug 263.69
Aug 262.85
Aug 263.02
Jul 262.72
Jul 262.98
Jul 263.1
Jul 263
Jul 263.18
Jun 262.93
Jun 262.83
Jun 262.78
Jun 262.96
May 262.87
May 263
May 263.28
May 263.29
May 263.41
Apr 263.09
Apr 263.12
Apr 263
Apr 262.8
Mar 263.09
Mar 263.32
Mar 263.2
Mar 263.16
Feb 262.87
Feb 263.02
Feb 262.79
Feb 262.39
Jan 262.92
Jan 262.92
Jan 262.8
Jan 262.95
Jan 262.84
Dec 252.83
Dec 252.64
Dec 252.97
Dec 252.86
Nov 252.9
Nov 252.92
Nov 252.3
Nov 252.46
Oct 252.53
Oct 252.53
Oct 252.13
Oct 252.35
Oct 252.56
Sep 252.15
Sep 252.06
Sep 252.4
Sep 252.19
Aug 251.91
Aug 251.76
Aug 251.81
Aug 251.79
Aug 251.86
Jul 251.89
Jul 251.86
Jul 252
Jul 251.55
Jun 251.4
Jun 251.45
Jun 251.39
Jun 251.44
May 251.21
May 251.24
May 251.01
May 250.82
May 250.9
Apr 250.74
Apr 250.73
Apr 250.7
Apr 250.65
Mar 250.77
Mar 250.84
Mar 250.89
Mar 250.86
Feb 250.9
Feb 251.26
Feb 250.89
Feb 250.82
Jan 250.85
Jan 250.81
Jan 250.81
Jan 250.76
Jan 250.69
Dec 240.68
Dec 240.65
Dec 240.72
Dec 240.72
Nov 240.74
Nov 240.73
Nov 240.77
Nov 240.76
Nov 240.76
Oct 240.76
Oct 240.78
Precipio, Inc.
PRPO
Stockpicker

Video analysis: PRPO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PRPO

PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?

zacks.com · 24 Aug 2026

PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?

Precipio and Biodesix take different approaches to cancer diagnostics, but which stock looks more compelling now? Let's dive in.

Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong

zacks.com · 21 Aug 2026

Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong

PRPO's second-quarter 2026 revenue momentum strengthens on higher diagnostic volumes and record product sales, alongside positive adjusted EBITDA and cash generation.

Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript

seekingalpha.com · 17 Aug 2026

Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript

Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript

Precipio Announces Q2-2026 Financial Results

globenewswire.com · 14 Aug 2026

Precipio Announces Q2-2026 Financial Results

Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and strengthens cash position Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and strengthens cash position

Precipio (NASDAQ:PRPO) Stock Price Passes Below Two Hundred Day Moving Average   – Should You Sell?

defenseworld.net · 1 Aug 2026

Precipio (NASDAQ:PRPO) Stock Price Passes Below Two Hundred Day Moving Average – Should You Sell?

Precipio, Inc. (NASDAQ: PRPO - Get Free Report) passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $25.12 and traded as low as $20.20. Precipio shares last traded at $21.65, with a volume of 21,130 shares trading hands. Analysts Set New Price Targets A number of

Precipio Announces Q2-2026 Shareholder Update Call

globenewswire.com · 31 Jul 2026

Precipio Announces Q2-2026 Shareholder Update Call

NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.   (NASDAQ: PRPO) , will be hosting its Q2-2026 shareholder update call on August 17th, 2026, at 5:00 PM ET.

PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?

zacks.com · 16 Jul 2026

PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?

Precipio and NeoGenomics take different approaches to cancer diagnostics, but which oncology stock looks more compelling now? Let's dive in.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.